Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | EOG | Common Stock | Options Exercise | $222K | +3.2K | +2.52% | $69.43 | 130K | Nov 10, 2021 | Direct | |
transaction | EOG | Common Stock | Disposed to Issuer | -$222K | -2.33K | -1.79% | $95.48 | 128K | Nov 10, 2021 | Direct | |
transaction | EOG | Common Stock | Tax liability | -$32.8K | -344 | -0.27% | $95.48 | 127K | Nov 10, 2021 | Direct | |
transaction | EOG | Common Stock | Options Exercise | $225K | +3K | +2.36% | $75.09 | 130K | Nov 10, 2021 | Direct | |
transaction | EOG | Common Stock | Disposed to Issuer | -$225K | -2.36K | -1.81% | $95.48 | 128K | Nov 10, 2021 | Direct | |
transaction | EOG | Common Stock | Tax liability | -$24.1K | -252 | -0.2% | $95.48 | 128K | Nov 10, 2021 | Direct | |
transaction | EOG | Common Stock | Options Exercise | $56.2K | +1.5K | +1.17% | $37.44 | 129K | Nov 10, 2021 | Direct | |
transaction | EOG | Common Stock | Disposed to Issuer | -$56.2K | -589 | -0.46% | $95.48 | 129K | Nov 10, 2021 | Direct | |
transaction | EOG | Common Stock | Tax liability | -$34.2K | -358 | -0.28% | $95.48 | 128K | Nov 10, 2021 | Direct | |
transaction | EOG | Common Stock | Sale | -$140K | -1.47K | -1.15% | $95.55 | 127K | Nov 10, 2021 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | EOG | Stock Appreciation Rights | Options Exercise | $0 | -3.2K | -24.95% | $0.00 | 9.63K | Nov 10, 2021 | Common Stock | 3.2K | $69.43 | Direct | F1 |
transaction | EOG | Stock Appreciation Rights | Options Exercise | $0 | -3K | -16.57% | $0.00 | 15.1K | Nov 10, 2021 | Common Stock | 3K | $75.09 | Direct | F2 |
transaction | EOG | Stock Appreciation Rights | Options Exercise | $0 | -1.5K | -8.28% | $0.00 | 16.6K | Nov 10, 2021 | Common Stock | 1.5K | $37.44 | Direct | F3 |
Id | Content |
---|---|
F1 | The SARs became exercisable in 25% increments beginning one year from the September 28, 2015 date of grant and on each of the next three grant date anniversaries. The SARs became fully exercisable on September 28, 2019. |
F2 | The SARs granted became exercisable in increments of 33%, 33% and 34% on each of the first three anniversaries, respectively, of the September 26, 2019 date of grant. The SARs will become fully exercisable on September 26, 2022. |
F3 | The SARs granted became exercisable in increments of 33.3%, 33.3% and 33.4% on each of the first three anniversaries, respectively, of the September 28, 2020 date of grant. The SARs will become fully exercisable on September 28, 2023. |